Announcements Trials
Browse Landscape

Phase

Phase 2 180Phase 3 63Phase 1/2 62Phase 1 53Phase 2/3 15Phase NA 11Phase EARLY_PHASE1 3Phase 4 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 11Thoracic 5Gynecologic 2Gastrointestinal 2Tumor-Agnostic 1Other solid neoplasm 1NET 1Head & Neck 1Endocrine 1

Conditions

Stomach Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Breast Neoplasms 1

Interventions

Oxaliplatin 21Capecitabine 19Fluorouracil 16Bevacizumab 15Esomeprazole 11Sorafenib 10Irinotecan 9Leucovorin 8Radiofrequency Ablation 7Propofol 7Bismuth 7Morphine 6Folfox protocol 6Amoxicillin 6lenvatinib 5gadolinium ethoxybenzyl DTPA 5Tetracycline 5Sevoflurane 5S 1 (combination) 5Gemcitabine 5Drug Therapy 5Control Groups 5sodium glycididazole 4fish oil triglycerides 4ferric carboxymaltose 4Ribavirin 4Hepatectomy 4HMPL-013 4Golytely 4Furazolidone 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Paclitaxel × Gastrointestinal × Clear all
NCT05183126 2026-03-06

Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer

University of Michigan Rogel Cancer Center

Phase 4 Recruiting
22 enrolled
BreastGastrointestinal

Breast Neoplasms, Esophageal Neoplasms, Stomach Neoplasms

NCT05603065 2023-06-29

TINES

First Affiliated Hospital Xi'an Jiaotong University

Phase 4 Unknown
32 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡